Novacure is not approved in UK and NWBO hasn't even applied to the countries you have listed . So they will be in mutually exclusive countries for foreseeable future if approved in UK. So your theory has no consequence for long term investors or for SP in near to mid term future.
Market Data 
Markets 
AI
